Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents?
Sign Up to like & getrecommendations! Published in 2020 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5152
Abstract: Erythropoiesis‐stimulating agents (ESAs), are used for treating chronic kidney disease (CKD)‐related anemia, contributing to CKD costs. The study was aimed at investigating direct healthcare costs of CKD patients treated with ESAs and the potential savings… read more here.
Keywords: use; chronic kidney; direct healthcare; erythropoiesis stimulating ... See more keywords
Direct healthcare costs of spinal disorders in Brazil
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Public Health"
DOI: 10.1007/s00038-019-01211-6
Abstract: ObjectivesTo estimate the direct healthcare costs of spinal disorders in Brazil over 2016.MethodsThis is a prevalence-based cost-of-illness study with a top-down approach from the perspective of the public healthcare system. All international Classification of Diseases… read more here.
Keywords: costs spinal; spinal disorders; disorders brazil; direct healthcare ... See more keywords
Direct healthcare costs of non-metastatic castration-resistant prostate cancer in Italy
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Technology Assessment in Health Care"
DOI: 10.1017/s0266462322003336
Abstract: Abstract Objectives The management of non-metastatic castration-resistant prostate cancer (nmCRPC) is rapidly evolving; however, little is known about the direct healthcare costs of nmCRPC. We aimed to estimate the cost-of-illness (COI) of nmCRPC from the… read more here.
Keywords: prostate cancer; non metastatic; healthcare costs; direct healthcare ... See more keywords
OP0100 Increase in direct healthcare costs in juvenile idiopathic arthritis over the past 10 years – results of a health insurance claims data analysis
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.5371
Abstract: Background Biological disease-modifying anti-rheumatic drugs (bDMARDs) are effective but expensive treatment options in juvenile idiopathic arthritis (JIA). The extent to which the healthcare costs of JIA have changed as a result of their increasing use… read more here.
Keywords: juvenile idiopathic; direct healthcare; treatment; increase ... See more keywords
Direct costs of inflammatory bowel diseases in a Finnish tertiary-level clinic
Sign Up to like & getrecommendations! Published in 2020 at "Frontline Gastroenterology"
DOI: 10.1136/flgastro-2020-101466
Abstract: Background Inflammatory bowel disease (IBD), Crohn’s disease (CD) and ulcerative colitis (UC) are chronic diseases associated with a high and continuous economic burden. The introduction of biologics has changed the distribution of costs over the… read more here.
Keywords: direct healthcare; level clinic; healthcare costs; tertiary level ... See more keywords
Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States
Sign Up to like & getrecommendations! Published in 2021 at "Emerging Infectious Diseases"
DOI: 10.3201/eid2701.190676
Abstract: Provision of safe drinking water in the United States is a great public health achievement. However, new waterborne disease challenges have emerged (e.g., aging infrastructure, chlorine-tolerant and biofilm-related pathogens, increased recreational water use). Comprehensive estimates… read more here.
Keywords: waterborne disease; direct healthcare; burden; united states ... See more keywords